Unless a woman is otherwise eligible, a dose of COVID-19 vaccine is not routinely recommended in pregnancy. Pregnant women who have previously been vaccinated should discuss with their healthcare provider whether to have a further dose during their pregnancy, based on an individual risk-benefit assessment. The risk of severe illness from Omicron infection has been shown to be low in pregnant women who have received 3 doses of COVID-19 vaccine.2,3 A dose during pregnancy may reduce the risk of severe COVID-19 in young infants through transplacental passage of antibodies.4-6
Omicron XBB.1.5-based vaccines are preferred in pregnancy based on the large body of evidence supporting the safety of monovalent mRNA vaccines in pregnancy. Although the latest mRNA COVID-19 vaccines have not been formally studied in pregnant women, ATAGI considers them suitable and safe for use in pregnant women. There are limited safety data on Nuvaxovid in pregnancy, however it can be used if the benefits to the individual outweigh the risks.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.